Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown:

Slides:

Advertisements

Similar presentations

University Industry Collaboration Guven Yalcintas, Ph.D. Vice President Technology Transfer Office The Research Foundation of SUNY Alfred, NY-April 27,

Advertisements

Biocorrosion Monitoring System - BIOX - Witold Michalowski Dirk Steinmann.

Technology Ventures Clinic Eric Menkhus Director, Technology Ventures Clinic Associate Clinical Professor, Sandra Day OConnor College of Law.

Cambridge Enterprise Commercialisation of technology out of University of Cambridge Sénat Delegation 14 March 2006 Boris Bouqueniaux.

Cleantech Incubation Europe Working Summit Peterborough, UK 4 June 2013 Lynne McGregor Lead Technologist High Value Manufacturing Technology Strategy.

Each team has to present a business plan for an imaginary start-up company to a group of savvy investors and industry experts drawn from our local business.

Intellectual Property Rights Regulations in Russia: Case of Government-Supported R&D Irina Dezhina Leading Researcher, Ph.D. Institute for the Economy.

Commercializing Discoveries: Disclosing your Intellectual Property By Ryan N. Fiorini, Ph.D., MBA, MHA Licensing and Commercialization Manager MUSC Foundation.

Principal Patent Analyst

North Carolina State University © 2014 Technology Transfer Outcomes February 27, 2014 Research Retreat Kelly B. Sexton, Ph.D. Director Office of Technology.

Towards Better Exploitation and Economic Impact: Developing the EPSRC Partnership with the University Vince Osgood Associate Director, Economic Impact.

High Impact Implementation for an Innovation-Driven Economy The Texas Industry Cluster Initiative.

Money Spinner YES Consultancy to Spin out Company Bruce Venning.

LOGO “ Add your company slogan ” AQUAESTUS “Heating longer for less” ®

Board of Directors MBA, FCA Chartered accountant: PWC Management consultancy: Reed Cons. Managing and Financial Director Juliane Klein MBA Business and.

Introduction Opportunity Market potential of recombinant drugs Problem Lack of manufacturing capacity Solution PharmOut: Contract BioManufacturing.

Shaping Business Strategy Through Competitive Intelligence: strategic use of Intellectual Property Information Training of Trainer’s Program, Teheran 9.

Joe Zilcosky Delaware Economic Development Office Emerging Technology Specialist Prepared By: Delaware Economic Development Office’s Center of Excellence.

Ronald J. Huss Associate Vice President for Research and Technology Transfer Director, Office of Technology Management phone:

Intellectual Property: Kenneth Kirkland, Ph.D. Executive Director, Iowa State University Research Foundation (ISURF) Director, Office of Intellectual Property.

Destruction of Industrial Biofilms Grant Burgess School of Marine science and Technology, Newcastle University.

© 2014 Foley Hoag LLP. All Rights Reserved. International Patent Protection for Emerging Companies WIPO Program on International IP Protection Suffolk.

 Dave Alburty, CEO, InnovaPrep, LLC  Maria Meyers, Executive Director, KCSourceLink  Dr. Gary Clapp, President & CEO, Institute for Industrial and.

The use of patents by a university spin-off. Sub-module BThe use of patents by a university spin-off 2/21 Structure of the case study University technology.

STAR Park – STAR One Science, Technology and Advanced Research A member of The Texas State University System.

Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.

2015 Startup Nomad Global Acceleration Application Team Name: Applicant Name:

WIPO Dispute Resolution in International Science & Technology April 25, 2005 Ann M. Hammersla Senior Counsel, Intellectual Property Massachusetts Institute.

Tech Launch Arizona Tech Transfer Arizona Rakhi Gibbons, Asst. Director for Biomedical and Life Sciences Licensing.

Technology Transfer and Assessment of Intellectual Assets Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. ( Vice President.

Director, DG RTD, Directorate International Cooperation

Page 1 New Models for Commercialization Federal Partners in Technology Transfer June 18, 2009 A presentation by: Tom Corr Chief Executive Officer Accelerator.

Page 1 IOP Genomics Workshop Patents and Patenting Biotech Inventions Annemieke Breukink, Ph.D. September 8th, 2009.

SMEs & IP Experiences in Wales Andrew Beale Director, IP Wales®

2006 Clean Tech Open NOT FOR DISTRIBUTION Aqua Pura Technologies, Inc. Water Management.

Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.

Ignite Technology Transfer NUI Galway Technology Transfer Office Seamus Coyne, Ph.D Neil Ferguson, Ph.D Commercialisation Executives Technology Transfer.

Rudjer Innovations Ltd Innovations and Technology Transfer Domagoj Oreb CEO Ref: RI-GM-CP v01 Zagreb, October 2009.

© Faveo Limited Faveo Limited Dr Joanne Morgan Chief Executive ®

WELSH EUROPEAN FUNDING OFFICE SMEs Innovation Development in Wales Strategy & Experience 13 October 2005 Dr. Emyr Roberts Chief Executive.

Policy on the Management of Intellectual Property in Technology Transfer Activities at CERN CERN/FC/5434/RA Technology Transfer Network Meeting – 10 th.

Bringing 5G to the World via a Millimeter-Wave Amplifier

Nanotechnologies: evolution and perspectives in the chemical industry EESC, Nanotechnology for a competitive chemical industry September 9, 2015 Dr. Pierre.

Guardbridge University of St Andrews May Guardbridge: Present.

Driving Innovation Competition Scope and Background Merlin Goldman 27 September 2011.

Research and Development: Best Practice Professor Mohamed El-Gomati OBE University of York, UK.

SECOND NATIONAL INNOVATION FORUM The West Midlands Regional Innovation Strategy (RIS / RIS+) 25 th October 2005 Sofia, Bulgaria Dr Clive Winters, Programmes.

OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.

Single Cell Analysis Systems for Therapeutic Discovery

Coalition for National Science Funding (CNSF) 

Iyad Alzaharnah, PhD – Director Innovation Center

Office of Technology Commercialization (OTC)

Initial Market Assessment

Patent & Licensing Management

Novosibirsk State University

Gestora brasileiro focada exclusivamente na área da saúde.

Cytogenetics Market | Opportunity Analysis and Industry Forecast,

Creating Technology-Based Commercialization Alliances

16/11/2018 Incentives (other than Fee Reductions) to Encourage Patenting from Universities – Developed Country Experience Bo Stenhuus Commercial Officer.

“Success Stories: From Lab To The Market – the US experience”

Impact of Fee Reductions on Ability of Universities to Access the Patent System – Developed Country Experience Anne Lane Executive Director UCL Business.

مالکیت فکری و حمایت های قانونی در تجاری سازی یافته های پژوهشی

Patenting from the perspective of a university in a developed country

MONETIZING IP and TECH TRANSFER The Patent Attorney’s Perspective

VYRUCHAI DENGI INVESTEMENT OPPORTUNITIES

A NEW WORD OF AGRICULTURAL BUSINESS

In Association with us at:

Presentation transcript:

Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown: Research and Development Director Professor of Cell Biology & Applied Virology Dr Amos Iorliam: Operations Director MBA Harvard University, LLP Ruth Kennedy-Walker: Finance Director MBA, FCA, Chartered accountant: PWC

COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion Cost of Corrosion in the Oil Industry

Microbial Influenced Corrosion

Metabolites Microbial Influenced Corrosion

COST OF PIPELINE CORROSION COST OF MIC £12.1 Billion £3.6 Billion £1.9 Billion Cost of MIC in the Oil Industry

MIC Mitigation/Maintenance Dewatering Physical Cleaning (Pigging) Flushing/Addition of Biocides Introduction of Chemical Inhibitors Internal pipeline coatings

MIC Phage Therapy

Lab Scale Results:  Reduced Biofilm Formation by up to 20%  Reduced MIC Causing Bacteria by 60%  Reduced Corrosion by up to 25% Phage Therapy Vs. Biocides/Inhibitors Phage AdditionBiocide Addition

Market Opportunity £1.9 Billion p.a£475 Million p.a

Where We Have Come From? Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 EPSRC Advanced Research Fellowship 1/9/2008 1/3/ /3/2013 International Patents Filed in Target Nations 1/5/ /5/2013 UK IP Granted 1/11/ /11/2010 UK Priority Applications 16/9/ /9/2013 IP License and Research Concordat Agreed with University 1/9/ /9/2012 Phage Application Experiment 1/9/ /9/2011 Development of Lab Scale Culture Techniques 1/9/ /9/2010 Identification and Isolation of Major MIC causing Bacteria and Associated Phages

Business Strategy: Years End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/1/ /1/2017 Continued R & D 1/1/ /1/2017 Identify Potential Licensees/ Building Market Presence 1/7/ /7/2016 Scale Up of Phage Application 1/7/ /3/2017 Production of Phage Culture 1/1/ /7/2014 Scale Up of Phage Culturing Techniques

Intellectual Property End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013 1/12/ /11/2016 Patents Granted in Target Nations 1/3/ /3/2013 International Patents Filed in Target Nations 1/9/ /9/2011 International PCT Applications 1/5/ /5/2013 UK IP Granted 1/11/ /11/2010 UK Priority Applications

Expenditure: Years 1 - 3

Projected Income: Years

Growth and Future Markets Gas Oil Wastewater Drinking water

Thank You